Zivo Bioscience
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $65 | $53 | $0 | $90 |
Gross Profit | 21 | 17 | 0 | 27 |
EBITDA | -1,020 | -1,632 | -4,208 | -1,596 |
EBIT | -1,553 | |||
Net Income | -1,033 | -1,640 | -4,211 | -1,601 |
Net Change In Cash | 65 | 53 | 0 | 90 |
Free Cash Flow | -266 | -476 | -1,430 | -905 |
Cash | 57 | 9 | 517 | 1,542 |
Basic Shares | 3,817 | 3,810 | 3,750 | 3,410 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $157 | $27 | $4 | $0 |
Gross Profit | 48 | 11 | 0 | |
EBITDA | -13,361 | -7,263 | -8,731 | -9,608 |
EBIT | -7,702 | -8,731 | -9,052 | |
Net Income | -13,384 | -7,777 | -8,745 | -9,396 |
Net Change In Cash | 157 | 27 | 4 | 0 |
Free Cash Flow | -4,313 | -5,799 | -7,102 | -6,803 |
Cash | 1,542 | 274 | 1,799 | 8,901 |
Basic Shares | 3,410 | 1,690 | 1,569 | 1,271 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.27 |
2025-06-30 | -$0.43 |
2025-03-31 | -$1.12 |
2024-12-31 | -$0.36 |
